Bing-Hao Chiang, PhD, shares his path from Taiwan to Fred Hutch, where he helps ensure proton therapy treatments are ...
Scientists at Fred Hutch Cancer Center and Seattle Children's Hospital have a new vision for cancer's origins. They argue that our focus on DNA mutations has led us astray, and that we should look ...
Teens and young adults looking for a way to kick the vaping habit can soon take advantage of two new Fred Hutch studies ...
Many drugs attack cancer by starving tumors of the fuels they need to grow and spread, whether it’s hormones, sugar, amino acids, fats or pro-growth signaling molecules. The basic idea is that if a ...
Vanessa Osorio Laughlin has noticed a perk of giving monthly to Fred Hutch Cancer Center — she gets thanked twelve times a year. Thirteen, if you count the acknowledgment letter at tax time.
Dr. Beth Mueller is a cancer and reproductive health epidemiologist whose research interests include maternal and child health, and environmental and occupational cancer risk factors. Specifically, ...
If you have an abnormal mammogram, breast lump, nipple discharge or other breast concern, the breast specialists at Fred Hutch Cancer Center’s Breast Health Program can help. We provide evaluations ...
Anyone who has a non-medical issue that could keep them from getting care can ask for help from a patient navigator. To request an appointment, call the supportive care patient care coordinator or ask ...
The Clinical Biostatistics Group consists of faculty biostatisticians, a staff scientist, and Statistical Research Associates (SRAs) who conduct independent research and collaborate with investigators ...
Three Fred Hutch scientists received research grants from the American Cancer Society to study how mutations in cell metabolism can lead to different types of cancer in different tissue types, how a ...
Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...
They are genes commonly associated with breast cancer in women, but in fact men who carry certain mutations in their BRCA1 or BRCA2 genes are at higher risk of developing certain types of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results